Biotech - Press Releases

Date	Title	Company
07-Dec-2020	Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study	Antengene Corporation Limited
06-Dec-2020	Syndax Pharmaceuticals Announces Additional Positive Data from Phase 1 Trial of Axatilimab in Patients with cGVHD	Syndax Pharmaceuticals, Inc.
06-Dec-2020	CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Potential Benefit in Preventing Acute GVHD at the 62nd American Society of Hematology Meeting	CTI BioPharma Corp.
06-Dec-2020	CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition	CARsgen Therapeutics Co. Ltd.
05-Dec-2020	Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE® Therapy AMG 701 At ASH 2020	Amgen
05-Dec-2020	Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia	Sysmex Inostics GmbH
04-Dec-2020	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PTC Therapeutics, Inc.
04-Dec-2020	PhagoMed Selected as Leading Young European Biotech Company	PhagoMed
04-Dec-2020	Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting	Cellular Biomedicine Group
04-Dec-2020	Marizyme, Inc. Expands Executive Team, Board of Directors	Marizyme, Inc.
04-Dec-2020	Pressure BioSciences Proposed Acquisition Partner Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster	Pressure BioSciences, Inc.
04-Dec-2020	Contract Research Organizations (CROs) Market to Reach $64.4 Billion by 2027, Growing at a CAGR of 6.5% From 2020 With COVID-19 Impact- Meticulous Research® Analysis	Meticulous Market Research Pvt. Ltd
04-Dec-2020	Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition	Rigel Pharmaceuticals, Inc.
04-Dec-2020	Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab	Alligator Bioscience
04-Dec-2020	Olympus Grows Respiratory Portfolio with Acquisition of Veran Medical Technologies, Inc.	Olympus
04-Dec-2020	Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study	Ascletis Pharma Inc.
04-Dec-2020	Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study	Ascletis Pharma Inc.
03-Dec-2020	enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer	enGene
03-Dec-2020	PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO(TM) (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels	PANTHERx Rare Pharmacy
03-Dec-2020	TheraCell Announces Expanded License Agreement With Australian Biotechnologies	TheraCell, Inc.